Senior insider sale
Chief Medical Officer at AVALO THERAPEUTICS, INC. — senior position signals high conviction
$1.59M
91.97K shares
What this filing means
DOYLE MITTIE plans to sell 91.97K shares of AVALO THERAPEUTICS, INC. valued at approximately $1.59M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/6/2026ACC: 0001950047-26-003276
Officer· Chief Medical Officer
Since Feb 2026
91.97K
Shares to sell
$1.59M
Approx. market value
65.80K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
4/6/2026
65.80KTotal acquired65.80K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/6/2026 | Exercise of Stock Options Cash | 65.80K | — |
| Total | 65.80K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
679.00
Market value
$10.9K
4/1/2026
—Completed
Units to sell
25.49K
Market value
$411.6K
3/16/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
65.80K
Market value
$1.17M
4/6/2026
Total
Units
91.97K
Value
$1.59M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/1/2026 | 679.00 | $10.9K | — | Completed |
3/16/2026 | 25.49K | $411.6K | — | Completed |
| Planned — Approximate Date | ||||
4/6/2026 | 65.80K | $1.17M | NASDAQ | Planned |
| Total | 91.97K | $1.59M | ||